Takeda Pharmaceutical (TAK) Inventory (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Inventory of $9.1 billion for Q2 2026, up 5.9% year-over-year from $8.6 billion in Q2 2025, and up 1.96% quarter-over-quarter from $8.9 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Inventory (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Inventory history runs 10 years deep, the most recent figure standing at $9.1 billion for Q2 2026.
- In Q2 2026, Inventory rose 5.9% year-over-year to $9.1 billion; the TTM figure through Jun 2026 stood at $9.1 billion (up 5.9% YoY), while the FY2026 annual figure was $9.3 billion, up 16.1% from the prior year.
- Inventory for Q2 2026 stood at $9.1 billion, up from $8.9 billion in the prior quarter.
- The five-year high for Inventory was $9.1 billion in Q4 2025, with the low at $6.6 billion in Q4 2022.
- The 5-year median for Inventory is $8.0 billion (2023), against an average of $8.0 billion.
- The sharpest annual moves came in 2022 and 2023: Inventory decreased 8.04% in 2022, then rose 20.56% in 2023.
- Takeda Pharmaceutical's Inventory stood at $6.6 billion in 2022, then grew by 20.56% to $7.9 billion in 2023, then rose by 3.61% to $8.2 billion in 2024, then increased by 11.53% to $9.1 billion in 2025, then slipped by 0.7% to $9.1 billion in 2026.
- Business Quant data shows TAK's Inventory at $9.1 billion in Q2 2026, $8.9 billion in Q1 2026, and $9.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 816.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 298.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.08 Bn |
| Mar 31, 2026 | 8.91 Bn |
| Dec 31, 2025 | 9.14 Bn |
| Sep 30, 2025 | 8.82 Bn |
| Jun 30, 2025 | 8.57 Bn |
| Mar 31, 2025 | 7.98 Bn |
| Dec 31, 2024 | 8.20 Bn |
| Sep 30, 2024 | 8.09 Bn |
| Jun 30, 2024 | 8.20 Bn |
| Mar 31, 2024 | 8.16 Bn |
| Dec 31, 2023 | 7.91 Bn |
| Sep 30, 2023 | 8.00 Bn |
| Jun 30, 2023 | 7.91 Bn |
| Mar 31, 2023 | 7.46 Bn |
| Dec 31, 2022 | 6.56 Bn |
| Sep 30, 2022 | 6.90 Bn |
| Jun 30, 2022 | 7.17 Bn |
| Mar 31, 2022 | 7.34 Bn |
| Dec 31, 2021 | 7.14 Bn |
| Sep 30, 2021 | 7.12 Bn |